RECQ helicases are deregulated in hematological malignancies in association with a prognostic value.

Viziteu, Elena; Kassambara, Alboukadel; Pasero, Philippe; Klein, Bernard; Moreaux, Jerome

Viziteu, Elena; Kassambara, Alboukadel; Pasero, Philippe; Klein, Bernard; Moreaux, Jerome.

Afiliación

Viziteu E; Institute of Human Genetics, CNRS-UPR1142, Montpellier, F-34396 France.
Kassambara A; Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Hôpital Saint-Eloi - CHRU de Montpellier, 80, av. Augustin Fliche, 34295 Montpellier, Cedex 5 France ; Institute of Human Genetics, CNRS-UPR1142, Montpellier, F-34396 France.
Pasero P; Institute of Human Genetics, CNRS-UPR1142, Montpellier, F-34396 France.
Klein B; Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Hôpital Saint-Eloi - CHRU de Montpellier, 80, av. Augustin Fliche, 34295 Montpellier, Cedex 5 France ; Institute of Human Genetics, CNRS-UPR1142, Montpellier, F-34396 France ; University of Montpellier 1, UFR de Méd
Moreaux J; Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Hôpital Saint-Eloi - CHRU de Montpellier, 80, av. Augustin Fliche, 34295 Montpellier, Cedex 5 France ; Institute of Human Genetics, CNRS-UPR1142, Montpellier, F-34396 France ; University of Montpellier 1, UFR de Méd

Biomark Res ; 4: 3, 2016.

Article en En | MEDLINE | ID: mdl-26877874

Palabras clave

Gene expression; Hematological malignancies; Prognostic markers; RECQ helicases; Therapeutic targets

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomark Res Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google